This sublease is a routine real estate cost-sharing arrangement with no material financial impact. Monitor the upcoming 10-K/T for any rent amounts or impairment implications, but no immediate trading catalyst.
Price Chart
Executive Summary
AnaptysBio entered into a sublease agreement with First Tracks Biotherapeutics for approximately 45,057 rentable square feet of its San Diego headquarters. The 12-month sublease transfers occupancy costs to First Tracks while AnaptysBio remains primarily liable under the master lease. This is a routine real estate transaction with no material financial impact disclosed.
Key Financial Metrics
Key Facts
- Sublease of ~45,057 rentable square feet at 10770 Wateridge Circle, San Diego to First Tracks Biotherapeutics
- 12-month initial term starting June 15, 2026, with extension options through April 2028
- First Tracks pays monthly Basic Rent plus Additional Rent under the Master Lease; AnaptysBio remains primarily liable to the master landlord
- First Tracks can terminate at any time with 3 months' notice
- No financial terms (dollar amounts, rent) were disclosed in the filing
Financial Impact
No financial figures disclosed; sublease transfers occupancy costs but AnaptysBio retains primary lease liability
Risk Factors
- AnaptysBio remains liable under the master lease if First Tracks defaults or terminates early
- No disclosed financial terms limit visibility into cost savings or income from the sublease
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-277505 |
| Document: 0001193125-26-277505-index-headers.html | 0001193125-26-277505 |
| Document: 0001193125-26-277505-index.html | 0001193125-26-277505 |
| Document: 0001193125-26-277505.txt | 0001193125-26-277505 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 12, 2026 7w ago | Institutional Cluster | $56.02 $53.87 | ▼ −3.84% | ▼ −2.09% | $48.53 (−13.37%) |
Jun 29, 2026 13w ago | 144 | $67.50 $53.61 | ▲ +20.58% | ▲ +19.55% | $48.53 (+28.10%) |
Jun 29, 2026 13w ago | DEFA14A | $67.50 $53.61 | ▼ −20.58% | ▼ −19.55% | $48.53 (−28.10%) |
Jun 26, 2026 13w ago | 144 | $65.97 $54.15 | ▲ +17.92% | ▲ +17.64% | $48.53 (+26.44%) |
Jun 22, 2026 14w ago | 8-K | $59.43 $50.29 | ▼ −15.38% | ▼ −16.54% | $48.53 (−18.34%) |
Jun 17, 2026 15w ago | 144 | $57.51 $54.15 | ▲ +5.84% | ▲ +6.38% | $48.53 (+15.61%) |
Jun 15, 2026 15w ago | 144 | $57.61 $62.51 | ▼ −8.51% | ▼ −8.31% | $48.53 (+15.76%) |
Jun 11, 2026 16w ago | 144 | $56.07 $66.39 | ▼ −18.41% | ▼ −16.63% | $48.53 (+13.45%) |
Jun 10, 2026 16w ago | 144 | $54.24 $66.59 | ▼ −22.77% | ▼ −20.88% | $48.53 (+10.53%) |
Jun 8, 2026 16w ago | 144 | $51.63 $67.33 | ▼ −30.40% | ▼ −28.95% | $48.53 (+6.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access